Cipla stock jumps to all-time high; Nuvama raises target price, sees 18% upside
Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.
Read MoreCipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.
Read MoreR K Swamy IPO: The price band for the issue has been fixed at Rs 270-288 per share.
Read MoreR K Swamy IPO: The price band for the issue has been fixed at Rs 270-288 per share.
Read MoreICICI Securities is bullish on Shyam Metalics and Energy recommended buy rating on the stock with a target price of Rs 815 in its research report dated March 08, 2024.
Read MoreICICI Securities is bullish on Shyam Metalics and Energy recommended buy rating on the stock with a target price of Rs 815 in its research report dated March 08, 2024.
Read MoreWith the award of this 306 MW capacity, Torrent’s renewable capacity under construction has increased to 1.7 gigawatt (GW)
Read More